{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T12:30:39Z","timestamp":1794227439107,"version":"4.9.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1124\/jpet.120.000323","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T02:20:12Z","timestamp":1604974812000},"page":"231-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Predictors of Early or Delayed Diastolic Dysfunction After Anthracycline-Based or Nonanthracycline Chemotherapy: A Pharmacological Appraisal"],"prefix":"10.1016","volume":"376","author":[{"given":"Giorgio","family":"Minotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierantonio","family":"Menna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Camilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Salvatorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Reggiardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.000323_bib1","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/sj.bjc.6605095","article-title":"Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer","volume":"100","author":"Altena","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1124\/jpet.120.000323_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1124\/jpet.120.000323_bib3","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2015.04.013","article-title":"Comprehensive echocardiographic detection of treatment-related cardiac dysfunction in adult survivors of childhood cancer: results from the St. Jude Lifetime Cohort Study","volume":"65","author":"Armstrong","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.120.000323_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ppedcard.2014.09.003","article-title":"Late cardiotoxicity in aging adult survivors of childhood cancer","volume":"36","author":"Armstrong","year":"2014","journal-title":"Prog Pediatr Cardiol"},{"key":"10.1124\/jpet.120.000323_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaccao.2020.02.016","article-title":"Longitudinal changes in echocardiographic parameters of cardiac function in pediatric cancer survivors","volume":"2","author":"Border","year":"2020","journal-title":"JACC CardioOncol"},{"key":"10.1124\/jpet.120.000323_bib6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.120.000323_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000486761","article-title":"Early diastolic dysfunction after cancer chemotherapy: primary endpoint results of a multicenter cardio-oncology study","volume":"63","author":"Calabrese","year":"2018","journal-title":"Chemotherapy"},{"key":"10.1124\/jpet.120.000323_bib8","first-page":"316","article-title":"Acute heart failure 29 years after treatment for childhood cancer","volume":"2","author":"Camilli","year":"2020","journal-title":"J Am Coll Cardiol Cardiooncology"},{"key":"10.1124\/jpet.120.000323_bib9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1634\/theoncologist.2014-0299","article-title":"Diastolic dysfunction occurs early in HER2-positive breast cancer patients treated concurrently with radiation therapy and trastuzumab","volume":"20","author":"Cao","year":"2015","journal-title":"Oncologist"},{"key":"10.1124\/jpet.120.000323_bib10","first-page":"S54","article-title":"Silent myocardial ischemia on cardiac SPECT with MIBI implies endothelial toxicity in cancer patients on multiagent chemotherapy","volume":"11","author":"Carboni","year":"2009","journal-title":"Eur Heart J Suppl"},{"key":"10.1124\/jpet.120.000323_bib11","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1200\/JCO.2007.10.9777","article-title":"American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects","volume":"25","author":"Carver","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1124\/jpet.120.000323_bib12","series-title":"Sample Size Calculations in Clinical Research","author":"Chow","year":"2008"},{"key":"10.1124\/jpet.120.000323_bib13","first-page":"295","article-title":"Effect of eplerenone on diastolic function in women receiving anthracycline-based chemotherapy for breast cancer","volume":"1","author":"Davis","year":"2019","journal-title":"J Am Coll Cardiol Cardiooncology"},{"key":"10.1124\/jpet.120.000323_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2826.2011.02119.x","article-title":"The heart: a novel gonadotrophin-releasing hormone target","volume":"23","author":"Dong","year":"2011","journal-title":"J Neuroendocrinol"},{"key":"10.1124\/jpet.120.000323_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","article-title":"Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies","volume":"69","author":"Elze","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.120.000323_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jacc.2017.05.019","article-title":"Arginine-nitric oxide metabolites and cardiac dysfunction in patients with breast cancer","volume":"70","author":"Finkelman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.120.000323_bib17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/gme.0b013e31820390a2","article-title":"Neuronal nitric oxide synthase inhibition improves diastolic function and reduces oxidative stress in ovariectomized-mRen2.Lewis Rats","volume":"18","author":"Jessup","year":"2011","journal-title":"Menopause"},{"key":"10.1124\/jpet.120.000323_bib18","first-page":"280","article-title":"Cancer therapy-related cardiac dysfunction of nonanthracycline chemotherapeutics. What is the evidence?","volume":"1","author":"Kamphuis","year":"2019","journal-title":"J Am Coll Cardiol Cardiooncology"},{"key":"10.1124\/jpet.120.000323_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MNM.0000000000000941","article-title":"Diastolic dysfunction can precede systolic dysfunction on MUGA in cancer patients receiving trastuzumab-based therapy","volume":"40","author":"Klein","year":"2019","journal-title":"Nucl Med Commun"},{"key":"10.1124\/jpet.120.000323_bib20","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.1074\/jbc.M308033200","article-title":"Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes","volume":"279","author":"Lim","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000323_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/jpet.118.249235","article-title":"Pharmacology of cardio-oncology: chronotropic and lusitropic effects of B-type natriuretic peptide in cancer patients with early diastolic dysfunction induced by anthracycline or nonanthracycline chemotherapy","volume":"366","author":"Menna","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000323_bib22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1124\/jpet.118.253104","article-title":"The endogenous lusitropic and chronotropic agent, B-type natriuretic peptide, limits cardiac troponin release in cancer patients with an early impairment of myocardial relaxation induced by anthracyclines","volume":"367","author":"Menna","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000323_bib23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1021\/tx800002r","article-title":"Cardiotoxicity of antitumor drugs","volume":"21","author":"Menna","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/jpet.120.000323_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.119.258178","article-title":"Pharmacology of ranolazine versus common cardiovascular drugs in patients with early diastolic dysfunction induced by anthracyclines or nonanthracycline chemotherapeutics: a phase 2b minitrial","volume":"370","author":"Minotti","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000323_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.120.000323_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.110.165860","article-title":"Pharmacological foundations of cardio-oncology","volume":"334","author":"Minotti","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000323_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"22","author":"Nagueh","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1124\/jpet.120.000323_bib29","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/sim.6782","article-title":"Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events","volume":"35","author":"Pavlou","year":"2016","journal-title":"Stat Med"},{"key":"10.1124\/jpet.120.000323_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2288-12-70","article-title":"Evaluation of the propensity score methods for estimating marginal odds ratios in case of small sample size","volume":"12","author":"Pirracchio","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1124\/jpet.120.000323_bib31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1200\/JCO.2016.68.7830","article-title":"Multidisciplinary approach to novel therapies in Cardio-Oncology research (MANTICORE 101-Breast): a randomized trial for the prevention of trastuzumab-associated cardiotoxicity","volume":"35","author":"Pituskin","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1124\/jpet.120.000323_bib32","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/sim.7273","article-title":"Firth\u2019s logistic regression with rare events: accurate effect estimates and predictions?","volume":"36","author":"Puhr","year":"2017","journal-title":"Stat Med"},{"key":"10.1124\/jpet.120.000323_bib33","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1056\/NEJMcp1511175","article-title":"Heart failure with preserved ejection fraction","volume":"375","author":"Redfield","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000323_bib34","doi-asserted-by":"crossref","first-page":"H392","DOI":"10.1152\/ajpheart.00124.2017","article-title":"Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction","volume":"313","author":"Saiki","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.120.000323_bib35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1634\/theoncologist.2014-0500","article-title":"Diastolic dysfunction following anthracycline-based chemotherapy in breast cancer patients: incidence and predictors","volume":"20","author":"Serrano","year":"2015","journal-title":"Oncologist"},{"key":"10.1124\/jpet.120.000323_bib36","first-page":"1559","article-title":"The concurrent use of aromatase inhibitors and radiotherapy induces echocardiographic changes in patients with breast cancer","volume":"35","author":"Skytt\u00e4","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1124\/jpet.120.000323_bib37","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.120.000323_bib38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2967\/jnumed.116.179697","article-title":"(13)N-Ammonia PET\/CT detection of myocardial perfusion abnormalities in beagle dogs after local heart irradiation","volume":"58","author":"Song","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1124\/jpet.120.000323_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcmg.2019.07.018","article-title":"Comprehensive assessment of changes in left ventricular diastolic function with contemporary breast cancer therapy","volume":"13","author":"Upshaw","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1124\/jpet.120.000323_bib40","doi-asserted-by":"crossref","unstructured":"Zamorano JL, Gottfridsson C, Asteggiano R, Atar D, Badimon L, Bax JJ, Cardinale D, Cardone A, Fejjen EAM and Ferdinandy P (2020) The cancer patient and cardiology. Eur J Heart Fail. DOI: 10.1002\/ejhf.1985 [published ahead of print]","DOI":"10.1002\/ejhf.1985"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:21:23Z","timestamp":1739964083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524257463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0022356524257463"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000323","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of Early or Delayed Diastolic Dysfunction After Anthracycline-Based or Nonanthracycline Chemotherapy: A Pharmacological Appraisal","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}